UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognosticmodels for cardiovascular events and bleeding in myocardial infarction survivors

Pasea, L; Chung, S-C; Pujades-Rodriguez, M; Moayyeri, A; Denaxas, S; Fox, KAA; Wallentin, L; ... Hemingway, H; + view all (2017) Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognosticmodels for cardiovascular events and bleeding in myocardial infarction survivors. European Heart Journal , 38 (14) pp. 1048-1055. 10.1093/eurheartj/ehw683. Green open access

[thumbnail of Published article]
Preview
Text (Published article)
Pasea_Personalising_decision_prolonged_dual_antiplatelet_therapy_VoR.pdf - Published Version

Download (424kB) | Preview
[thumbnail of Supplementary information]
Preview
Text (Supplementary information)
Pasea_Personalising_decision_prolonged_dual_antiplatelet_therapy_Supplementary.pdf

Download (1MB) | Preview

Abstract

AIMS: The aim of this study is to develop models to aid the decision to prolong dual antiplatelet therapy (DAPT) that requires balancing an individual patient’s potential benefits and harms. METHODS AND RESULTS: Using population-based electronic health records (EHRs) (CALIBER, England, 2000–10), of patients evaluated 1 year after acute myocardial infarction (MI), we developed (n = 12 694 patients) and validated (n = 5613) prognostic models for cardiovascular (cardiovascular death, MI or stroke) events and three different bleeding endpoints. We applied trial effect estimates to determine potential benefits and harms of DAPT and the net clinical benefit of individuals. Prognostic models for cardiovascular events (c-index: 0.75 (95% CI: 0.74, 0.77)) and bleeding (c index 0.72 (95% CI: 0.67, 0.77)) were well calibrated: 3-year risk of cardiovascular events was 16.5% overall (5.2% in the lowest- and 46.7% in the highest-risk individuals), while for major bleeding, it was 1.7% (0.3% in the lowest- and 5.4% in the highest-risk patients). For every 10 000 patients treated per year, we estimated 249 (95% CI: 228, 269) cardiovascular events prevented and 134 (95% CI: 87, 181) major bleeding events caused in the highest-risk patients, and 28 (95% CI: 19, 37) cardiovascular events prevented and 9 (95% CI: 0, 20) major bleeding events caused in the lowest-risk patients. There was a net clinical benefit of prolonged DAPT in 63–99% patients depending on how benefits and harms were weighted. CONCLUSION: Prognostic models for cardiovascular events and bleeding using population-based EHRs may help to personalise decisions for prolonged DAPT 1-year following acute MI.

Type: Article
Title: Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognosticmodels for cardiovascular events and bleeding in myocardial infarction survivors
Open access status: An open access version is available from UCL Discovery
DOI: 10.1093/eurheartj/ehw683
Publisher version: https://doi.org/10.1093/eurheartj/ehw683
Language: English
Additional information: Copyright © The Author 2017. Published on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords: Prognosis, Myocardial infarction, Bleeding
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science > Population Science and Experimental Medicine
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Health Informatics
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Health Informatics > Clinical Epidemiology
URI: https://discovery-pp.ucl.ac.uk/id/eprint/1546848
Downloads since deposit
11,628Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item